FDA — authorised 30 August 2018
- Application: NDA210807
- Marketing authorisation holder: MSD MERCK CO
- Local brand name: DELSTRIGO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Doravirine/Lamivudine/Tenofovir in United States
FDA authorised Doravirine/Lamivudine/Tenofovir on 30 August 2018
Marketing authorisation
Doravirine/Lamivudine/Tenofovir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is Doravirine/Lamivudine/Tenofovir approved in United States?
Yes. FDA authorised it on 30 August 2018.
Who is the marketing authorisation holder for Doravirine/Lamivudine/Tenofovir in United States?
MSD MERCK CO holds the US marketing authorisation.